HYRIMOZ ® (adalimumab-adaz) is a prescription medicine called a tumor necrosis factor (TNF) blocker used: To reduce the signs and symptoms of: Moderate to severe rheumatoid arthritis (RA) in adults. HYRIMOZ can be used alone, or with methotrexate, or with certain other medicines.

HYRIMOZ® is an adalimumab biosimilar manufactured by Sandoz Inc. and indicated for the treatment of various inflammatory conditions.

HYRIMOZ® is administered using the Sensoready® pen, an autoinjector designed with features that patients can see, hear, and feel. Hyrimoz dosing across indications

Dec 21, 2022 · Hyrimoz (adalimumab) is a biologic disease-modifying antirheumatic drug (DMARD). It works by blocking tumor necrosis factor (TNF), a protein in your body that plays a role in inflammation. By blocking TNF, Hyrimoz (adalimumab) lowers inflammation in different parts of your body.

Mar 25, 2025 · Learn about the side effects of Hyrimoz (adalimumab), from common to rare, for consumers and healthcare professionals.

Apr 10, 2024 · HYRIMOZ is a tumor necrosis factor (TNF)-blocker indicated for: • Rheumatoid Arthritis (RA) : reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. •

Dec 19, 2024 · Hyrimoz Prefilled Pen is used to treat juvenile idiopathic arthritis in adults and children at least 2 years old. Hyrimoz Prefilled Pen is also used for the treatment of Crohn's disease in adults and children at least 6 years old.

Nov 6, 2024 · Hyrimoz (adalimumab-adaz) is a tumor necrosis factor (TNF)-blocker biosimilar to Humira (adalimumab) indicated for treatment of rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), psoriatic arthritis, ankylosing spondylitis, adult Crohn's disease, ulcerative colitis (UC), and plaque psoriasis. What Are Side Effects of Hyrimoz?

Dec 18, 2024 · Uses for Hyrimoz. Adalimumab-adaz injection is used to treat the symptoms and prevent the progression of moderate to severely active rheumatoid arthritis and active ankylosing spondylitis. It is used in children 2 years of age and older for juvenile idiopathic arthritis.

Hyrimoz contains the active substance adalimumab, a medicine that acts on your body’s immune (defence) system. Hyrimoz is intended for the treatment of the following inflammatory diseases: rheumatoid arthritis, polyarticular juvenile idiopathic …